Multi-hit genetic lesions and a stress-imprinted immune transcriptome define the inflammatory pathology in ALS patients

Technical Summary: Multi-hit genetic lesions and a stress-imprinted immune transcriptome define the inflammatory pathology in ALS patients

Problem Statement
Amyotrophic lateral sclerosis (ALS) is a genetically heterogeneous neurodegenerative disease characterized by motor neuron loss. While familial cases are linked to specific mutations (e.g., SOD1, FUS, C9orf72), the majority of cases are sporadic, and even familial forms often lack a single fully penetrant variant. The genetic basis of disease heterogeneity and its relationship to downstream pathogenic programs, particularly within the peripheral immune system, remains incompletely resolved. Although neuroinflammation is a known feature of ALS, the specific immune populations driving disease-associated inflammatory programs and the genetic architecture linking susceptibility to immune remodeling are not fully defined.

Methodology
The study employed an integrated approach combining whole-genome sequencing (WGS) and single-cell RNA sequencing (scRNA-seq) to define genomic and immune correlates of ALS.

1. Genomic Analysis: The authors performed WGS on peripheral blood mononuclear cells (PBMCs) from a monozygotic twin pair discordant for ALS. This design allowed for the differentiation of shared inherited susceptibility variants from twin-specific variants that might influence disease penetrance or resilience. Variants were filtered and annotated to identify those linked to neurodegeneration, RNA metabolism, and immune function.
2. Single-Cell Transcriptomics: scRNA-seq was conducted on PBMCs from three ALS patients (including the affected twin) and two healthy controls using the 10x Genomics Chromium platform. After quality control, 33,667 high-quality cells were retained.
3. Data Analysis: Unsupervised clustering identified 13 distinct immune clusters. Cell types were annotated using canonical markers and the SingleR package. Differential gene expression analysis (Wilcoxon rank-sum test) and Gene Set Enrichment Analysis (GSEA) were performed to characterize transcriptional states and pathway activation across immune subsets.

Key Contributions and Results

• Multi-Hit Genetic Architecture: The genomic analysis of the discordant twin pair revealed that ALS manifestation is not driven by a single deterministic mutation. Instead, the data support a "multi-hit" model.

  • Shared Variants: Both twins shared variants in genes linked to neuronal maintenance and stress signaling (e.g., ALS2, NEK1, SETX, UNC13A).
  • Patient-Enriched Variants: The affected twin carried specific variants in genes with established relevance to ALS biology, including TARDBP (TDP-43), FUS, ANG, and ATXN2L (RNA metabolism/stress), as well as PRF1 (cytotoxic immune function).
  • Healthy-Twin Variants: The unaffected twin carried variants in canonical ALS genes such as C9orf72 and HNRNPA1, suggesting that the mere presence of a variant in these genes does not guarantee disease, reinforcing the need for a combinatorial genetic model.

• Systemic Stress-Imprinted Immune Transcriptome: scRNA-seq revealed broad remodeling of the peripheral immune compartment in ALS, characterized not by the emergence of new cell types, but by the alteration of existing populations toward a stress-adapted state.

  • Innate-Like Enrichment: There was a relative enrichment of innate-like lymphocyte populations, specifically Natural Killer (NK) cells, Mucosal-Associated Invariant T (MAIT) cells, and $\gamma\delta$ T cells.
  • Transcriptional Reprogramming: Across multiple immune subsets (CD4+ T, CD8+ T, B cells, monocytes, dendritic cells), ALS samples exhibited upregulation of inflammatory and stress-response pathways. Key enriched pathways included TNF-$\alpha$/NF-$\kappa$B signaling, IFN-$\gamma$ response, hypoxia, reactive oxygen species (ROS), and ribosomal stress.
  • RNA Metabolism Dysregulation: The data highlighted altered expression of non-coding RNAs (e.g., SNHG family, LINC01578) and ribosomal proteins across immune cells, suggesting that post-transcriptional dysregulation extends beyond neurons to the peripheral immune system.

• NK and $\gamma\delta$ T Cells as Dominant Effectors: The study identified NK cells and $\gamma\delta$ T cells as the primary drivers of the inflammatory output in ALS.

  • NK Cells: Showed the most extensive transcriptional remodeling, with strong enrichment for TNF-$\alpha$/NF-$\kappa$B, IFN-$\gamma$, hypoxia, and cytotoxicity pathways. They were the dominant source of cytotoxicity genes (GZMB, GZMA, PRF1) and inflammatory cytokines.
  • $\gamma\delta$ T Cells: Exhibited a clear ALS-associated program with particularly strong enrichment for chemokine genes (CCL3, CCL4, CCL5), suggesting a role in leukocyte recruitment and inflammatory crosstalk.
  • Other Subsets: While CD4+ and CD8+ T cells, B cells, and monocytes also showed stress-adapted signatures, their inflammatory output was less pronounced compared to the innate-like lymphocytes.

Significance and Claims
The paper proposes an integrated model where ALS is a multi-hit immune-neurodegenerative disorder. The authors claim that:

1. Genetic Susceptibility: Disease risk arises from a combination of shared background variants and patient-enriched alterations in RNA metabolism and immune function genes, rather than a single mutation.
2. Systemic Stress State: ALS-associated genetic variants are linked to a systemic, stress-imprinted immune transcriptome distributed across PBMC subsets, indicating that RNA/proteostasis dysfunction has systemic consequences beyond the central nervous system.
3. Innate Effector Circuit: The inflammatory and cytotoxic output of the remodeled immune landscape is funneled predominantly through NK cells and $\gamma\delta$ T cells. These populations act as the principal inflammatory amplifiers in ALS.

The authors conclude that these findings identify NK cells and $\gamma\delta$ T cells as candidate peripheral cellular biomarkers and potential immunoregulatory targets. They emphasize that while the data are transcriptional and associative, they provide a mechanistic structure linking inherited susceptibility to peripheral immune remodeling. The study acknowledges limitations, including the modest cohort size and the lack of protein-level validation, noting that functional validation is required to establish causality.